Apogee Therapeutics, Inc. (APGE)

NASDAQ

$--

(--)

Market Closed

Apogee Therapeutics, Inc. (APGE) Live Price Chart

Last updated: ⁦2026-10-11 22:12:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Apogee Therapeutics, Inc. (APGE) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Apogee Therapeutics, Inc. (APGE) Latest Closing Stock Price

Apogee Therapeutics, Inc. (APGE) last closed at $-- as of --, -- from the previous close of $--.

During the latest regular trading session, APGE traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.

Apogee Therapeutics, Inc. (APGE) 7-Day Stock Price Change

Over the past seven days, Apogee Therapeutics, Inc. (APGE) moved from $134,85 to $135,07, representing a gain of 0,16% ($0,22).

The stock traded between $134,81 and $135,09 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.

The average daily volume was 1,74 million shares, up versus the previous seven-day period, indicating higher trading activity.

What is Apogee Therapeutics, Inc. (APGE)?

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Apogee Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	261
Exchange	NASDAQ
Company Website	https://www.apogeetherapeutics.com

How to Buy Apogee Therapeutics, Inc. (APGE) Stock on MEXC

Eligible investors can buy real shares of Apogee Therapeutics, Inc. (APGE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for APGE and Place Your Order

Open the RealStocks trading page and search for APGE. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Apogee Therapeutics, Inc. (APGE) stock price today?

Apogee Therapeutics, Inc. (APGE) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is APGE stock going up or down today?

As of --, APGE is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is APGE pre-market price?

As of --, APGE is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is APGE after-hours price?

As of --, APGE is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is APGE stock trading now?

APGE trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does APGE sit relative to its 52-week high and low?

Over the past 52 weeks, APGE has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Apogee Therapeutics, Inc. in?

Apogee Therapeutics, Inc. (APGE) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Apogee Therapeutics, Inc.'s market capitalization and where is it listed?

Apogee Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is APGE valued in terms of P/E ratio and EPS?

APGE trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Apogee Therapeutics, Inc. pay a dividend?

Apogee Therapeutics, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.